- Release Date: 03/05/23 08:47
- Summary: First patient enrolled in the TRIPP-FFX Clinical Study
- Price Sensitive: Yes
- Download Document 244.78KB
- Forums
- ASX - By Stock
- OSL
- Ann: First patient enrolled in the TRIPP-FFX Clinical Study
OSL
oncosil medical ltd
Add to My Watchlist
0.00%
!
$1.20

Ann: First patient enrolled in the TRIPP-FFX Clinical Study
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.20 |
Change
0.000(0.00%) |
Mkt cap ! $17.06M |
Open | High | Low | Value | Volume |
$1.24 | $1.24 | $1.17 | $52.67K | 44.11K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11 | $1.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.21 | 5157 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11 | 1.200 |
2 | 8974 | 1.170 |
1 | 10000 | 1.160 |
1 | 7500 | 1.080 |
2 | 19761 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.210 | 5157 | 1 |
1.240 | 4626 | 2 |
1.245 | 2418 | 1 |
1.250 | 46029 | 2 |
1.300 | 1500 | 1 |
Last trade - 13.05pm 01/07/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online